FATE - Fate Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FATE is currently covered by 4 analysts with an average price target of $6.58. This is a potential upside of $8.9 (180%) from yesterday's end of day stock price of $2.35.

Fate Therapeutics's activity chart (see below) currently has 140 price targets and 124 ratings on display. The stock rating distribution of FATE is 50% HOLD and 50% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.58% with an average time for these price targets to be met of 123 days.

Highest price target for FATE is $8, Lowest price target is $3.5, average price target is $6.58.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 14-Aug-2026.

Currently out of the existing stock ratings of FATE, 3 are a HOLD (50%), 3 are a BUY (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-Aug-2024

$8

$5.69 (246.32%)

$6

1 months 1 days ago
(14-Aug-2026)

20/25 (80%)

$5.43 (211.28%)

240

Hold Since 27-Mar-2023

$3.5

$1.19 (51.52%)

$2.5

1 months 1 days ago
(14-Aug-2026)

3/5 (60%)

$0.93 (36.19%)

129

Buy Since 04-May-2026

$7

$4.9 (233.33%)

$7

3 months 7 days ago
(08-Jun-2026)

0/7 (0%)

$5.09 (266.49%)

Hold Since 27-Feb-2024

$7

$4.9 (233.33%)

$5

10 months 19 days ago
(27-Oct-2025)

11/16 (68.75%)

$5.45 (351.61%)

142

Buy Since 12-Mar-2020

$7

$4.9 (233.33%)

1 years 12 days ago
(03-Sep-2025)

1/4 (25%)

$6 (600.00%)

36

Show more analysts

Please expand the browser size to see the chart

What is FATE (Fate Therapeutics) average time for price targets to be met?

On average it took 123 days for the stock forecasts to be reached, with an average price target met ratio of 53.58%.

Which analyst most recently updated their price target on FATE (Fate Therapeutics)?

Edward Tenthoff

Which analyst has the most public recommendations on FATE (Fate Therapeutics)?

Edward Tenthoff works at PIPER SANDLER and has 3 price targets and 2 ratings on FATE

Which analyst is the currently most bullish on FATE (Fate Therapeutics)?

Edward White with the highest potential upside of $113.76

Which analyst is the currently most reserved on FATE (Fate Therapeutics)?

Peter Lawson with the lowest potential downside of -$0.31

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?